Work

429: Effects of elexacaftor/tezacaftor/ivacaftor on the CF sputum microbiome: Preliminary analysis from the Promise study

Year: 2021

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(21)01853-1

Authors: S. Morgan, A. Vo, W. Ni, M. Radey, K. McGeer, S. Rowe, P. Jorth, S. Singh, D. Nichols, P. Singh

Institutions: University of Maryland, Baltimore, University of Maryland Medical Center, University of Oregon, Human Genome Sciences (United States), California Institute of Technology

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3207660728

FWCI: 0.143

Cites:

Cited by: 1

Related to: 10